Document:

EX-10.1

 Exhibit 10.1 

AMENDMENT 

TO MANUFACTURING AND SUPPLY AGREEMENT 

THIS AMENDMENT (this “Amendment”) to the Manufacture and Supply Agreement dated as of December 8, 2009
(the “Agreement”) is entered into as of the 31st day of December, 2013 (the “Amendment Effective Date”), by and between Columbia Laboratories,
(Bermuda) Ltd., a limited company existing and organized under the laws of Bermuda, having a place of business at Canon’s Court, 22 Victoria Street, Hamilton HM 12, Bermuda (“Columbia”), and Fleet Laboratories
Limited, a limited private company existing and organized under the laws of England, having a place of business at 94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom (“Fleet”). 

WHEREAS, Columbia and Fleet entered into the Agreement pursuant to which Fleet has agreed to manufacture and supply to Columbia, and Columbia
has agreed to purchase, certain Products; and 
 WHEREAS, Columbia and Fleet have determined that it is in their respective best interests
to amend the Agreement to: (i) extend the Term; (ii) provide for an expiration date of the Agreement; and (iii) modify certain quality matters. 

NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, Columbia and Fleet agree as follows: 
 1. Capitalized terms used but not defined in this Amendment shall have the meanings ascribed to such
terms in the Agreement 
 2. Section 12.1 of the Agreement, entitled Term, is hereby revised to provide in its entirety as follows: 

12.1 Term. Unless terminated earlier pursuant to Section 12.2 below, the initial term of this Agreement shall expire on
December 31, 2020 (“Initial Term”) and shall be automatically extended for additional periods of two (2) years (each a “Renewal Term”) and together with the Initial Term, the “Term”, unless either party gives
to the other party, not less than six (6) months prior to expiration of the Initial Term or any Renewal Term, written notice of its intention not to extend this Agreement; provided, however, that upon termination of this Agreement Fleet agrees
to perform its obligations under this Agreement for the earlier of one year or Columbia’s engagement and qualification of an alternative manufacturer of the Product. 

 3. Commencing as of the Amendment Effective Date and continuing until such time as Columbia provides Fleet with
not less than 60 days prior written notice of its intent to require Fleet to reinstate such compliance, the parties agree that Fleet shall not be obligated to comply with FDA regulatory standards and obligations, in general, unless otherwise
specifically required by applicable law. For the avoidance of doubt, compliance with all other applicable regulatory standards including those of MHRA and the European Medicines Agency shall remain in effect through-out the period of tolling of the
FDA obligations. 
 4. Section 13.1 of the Agreement, entitled Notices, is hereby amended to provide new contact information for Columbia Laboratories,
Inc. as follows: 
 With Copy to: 

Columbia Laboratories, Inc. 
 4
Liberty Square 
 Fourth Floor 

Boston, MA 02109 
 Tel: (617)
639-1500 
 Fax: (617) 482-0618 

Attention: General Counsel 
 5. All other terms
and conditions of the Agreement remain in full force and effect. Except as expressly provided in this Amendment, the Agreement shall remain unmodified and is hereby ratified and affirmed. The execution, delivery, and effectiveness of this Amendment
shall not, except as expressly provided herein, operate as a waiver of any right, power, or remedy of Columbia or Fleet under the Agreement. 
 6. This
Amendment, together with the Agreement, sets forth the entire agreement and understanding between the parties as to the subject matter hereof and thereof and merges all prior discussions and negotiations between them, and neither of the parties
shall be bound by any conditions, definitions, warranties, understandings or representations with respect to such subject matter other than as expressly provided herein and therein or as duly set forth on or subsequent to the date hereof in writing
and signed by a proper and duly authorized officer or representative of the party to be bound thereby. 
 7. This Amendment may be signed in counterparts,
each and every one of which shall be deemed an original, notwithstanding variations in format or file designation which may result from the electronic transmission, storage and printing of copies of this Amendment from separate computers or
printers. Executed signatures pages to this Amendment may be delivered by facsimile or a portable document format (PDF) copy (including copy(ies) sent by e-mail) and all such shall be deemed as if actual signature pages had been delivered. 

*-*-*-* 
 (Signature Page Follows)

  
 2 

 IN WITNESS WHEREOF, the parties have duly executed this Amendment as of the Amendment Effective
Date. 
  

			
	COLUMBIA LABORATORIES (BERMUDA), LTD.
		
	By:	 	/s/ Frank Condella
	 Name:
 Title:
	 	 Frank Condella
 President and
CEO

  

			
	FLEET, LABORATORIES LIMITED
		
	By:	 	/s/ Hanna Coonagh
	 Name:
 Title:
	 	 Hanna Coonagh
 Managing Director
Fleet

  
 [Signature Page to
Amendment]EX-10.52

 Exhibit 10.52 

AMENDMENT 
 TO SALE SUPPLEMENTS

 This Amendment (the “Amendment”), dated as of February 4, 2014, is between Ocwen Loan Servicing, LLC, a Delaware limited
liability company (“Seller”), HLSS Holdings, LLC, a Delaware limited liability company (“Holdings”) and Home Loan Servicing Solutions, Ltd. (“HLSS” and, together with Holdings, the “Purchasers”): 

WITNESSETH: 
 WHEREAS, Seller and
Holdings entered into that certain Master Servicing Rights Purchase Agreement, dated as of February 10, 2012 (as amended, supplemented and modified from time to time, the “Original Agreement”), with respect to the sale by Seller and
the purchase by Holdings of certain Rights to MSRs, Servicing Rights and other assets; 
 WHEREAS, Seller and Holdings terminated the
Original Agreement pursuant to certain Master Servicing Rights Purchase Agreement, dated as of October 1, 2012 (as amended, supplemented and modified from time to time, the “Agreement”), which also provided for the sale by Seller and
the purchase by Holdings of certain Rights to MSRs, Servicing Rights and other assets; 
 WHEREAS, Seller and Purchasers entered into
certain Sale Supplements identified in Exhibit A (collectively, as amended, supplemented and modified from time to time, the “Sale Supplements”); and 

WHEREAS, Seller and Purchasers desire to amend the Sale Supplements to amend certain definitions; 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and in consideration of the
mutual covenants herein contained, the parties hereto hereby agree as follows: 
 RECITALS 

Section 1. Amendment of Sale Supplements. The Sale Supplements shall be deemed amended as follows: 

(a) Article II of the Sale Supplements is hereby amended by adding a new Section 2.7 at the end thereof as follows: 

“2.7 Refinancing of Mortgage Loans. If any mortgage loan (“Refinanced Mortgage Loan”) included in the sale of Rights to
MSRs for any Servicing 

 
Agreement listed in Schedule 1 of the Sale Supplements is refinanced by Ocwen Financial Corporation, its affiliates or its vendors, the Seller hereby sells, assigns, transfers and conveys, in
each case, without recourse except as provided herein, free and clear of any Liens, (the “Transfer of New Mortgage Loans”) to (i) HLSS all of its rights, title and interest in and to all of the Excess Servicing Fees for the related
mortgage loan (“New Mortgage Loan”), and (ii) to Holdings, any and all right, title and interest in and to all of the Rights to MSRs for the related New Mortgage Loan. The Transfer of New Mortgage Loans will be effective on the date
on which a Refinanced Mortgage Loan is prepaid by the related New Mortgage Loan. On such date, the Seller shall execute and deliver an agreement, with a schedule of mortgage loans, documenting the Transfer of the Excess Servicing Fees and Rights to
MSRs of New Mortgage Loans to the Purchaser. For the avoidance of doubt, any New Mortgage Loan shall be deemed to be included in the list of servicing agreements listed in Schedule I of the related Sale Supplement. 

The above Section 2.7 Refinancing of Mortgage Loans shall only apply when the aggregate unpaid principal balance of all Refinanced
Mortgage Loans refinanced by Ocwen Financial Corporation, its affiliates or its vendors, exceeds 0.50% of the aggregate unpaid principal balance, as measured at the beginning of the most recent calendar year plus the weighted average of the unpaid
principal balance of any Rights to MSRs sold to Purchaser during the calendar year, of all mortgage loans for which the Rights to MSRs have been sold to HLSS under the Master Servicing Rights Purchase Agreement.” 

(b) Section 7.2 of the Sale Supplements is hereby amended by deleting it in its entirety and replacing it with the
following: 
 “Performance Fee. In addition to the Seller Monthly Servicing Fee, Holdings shall pay to Seller for each calendar
month during which Seller is servicing Mortgage Loans with respect to Deferred Servicing Agreements pursuant to this Sale Supplement a performance fee (“Performance Fee”) equal to the greater of (a) zero and (b) (x) the
excess, if any, of the aggregate of all Servicing Fees actually received by Purchasers with respect to the Deferred Servicing Agreements and pursuant to the Transferred Servicing Agreements (whether directly pursuant to such Transferred Servicing
Agreements or pursuant to this Sale Supplement) during such calendar month over the sum of (i) the Monthly Servicing Fee for such calendar month and (ii) the Retained Servicing Fee for such calendar month multiplied by (y) a fraction,
(i) the numerator of which is the average unpaid principal balance of all Mortgage Loans subject to the Deferred Servicing Agreements during such calendar month and (ii) the denominator of which is equal to the sum of the average unpaid
principal balance of all Mortgage Loans subject to the Deferred Servicing Agreements during such calendar month and the average unpaid principal balance of all Mortgage Loans subject to the Transferred Servicing Agreements during such calendar
month, or such other allocation percentage which is agreed by Seller and Holdings (the “Allocation Percentage”). 

  
 2 

 
The Performance Fee, if any, for any calendar month will be reduced by an amount equal to One-Month LIBOR (calculated using the arithmetic mean of daily rates for the period published by British
Bankers’ Association) plus 2.75% of the Excess Servicing Advances, if any, for such month multiplied by the Allocation Percentage, and the amount of any such reduction in the Performance Fee shall be retained by Holdings. If the Closing Date
does not occur on the first day of a calendar month, the Performance Fee for the period from the Closing Date to the last of the calendar month in which the Closing Date occurs shall be calculated in a pro rata manner based on the number of days in
such period. Notwithstanding any provision in this Sale Supplement to the contrary, in the event Holdings has failed to pay Seller any Seller Monthly Servicing Fee or Performance Fees that are past due after ten (10) Business Days of Holdings
receiving notice of such failure, Seller shall not be required to continue to act as servicer until such time as Holdings has fully paid such past due Seller Monthly Servicing Fee or Performance Fee; provided that Holdings shall not have notified
Seller that it disputes the occurrence or amount of such past due Seller Monthly Servicing Fee or Performance Fee.” 

(c) This amendment shall be deemed effective as of October 1, 2013. 

Section 2. Limited Effect. Except as expressly amended and modified by this Amendment, the Agreement and the Sale Supplements
shall continue to be, and shall remain, in full force and effect in accordance with their terms. 
 Section 3. Counterparts.
This Amendment may be executed by each of the parties hereto on any number of separate counterparts, each of which shall be an original and all of which taken together shall constitute one and the same instrument. 

Section 4. GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK,
WITHOUT REFERENCE TO ITS CONFLICT OF LAW PROVISIONS (OTHER THAN SECTION 5-1401 AND SECTION 5-1402 OF THE GENERAL OBLIGATIONS LAW) AND THE OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER AND THEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH
SUCH LAWS. 
 Section 5. Definitions. Capitalized terms used but not defined herein have the meaning set forth in the Agreement
and Sale Supplements. 
 [SIGNATURE PAGE FOLLOWS] 

  
 3 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered by its respective
officer thereunto duly authorized as of the date above written. 
  

			
	OCWEN LOAN SERVICING, LLC
		
	By:	 	 /s/ Richard Cooperstein

	Name:	 	Richard Cooperstein
	Title:	 	Treasurer
	
	HLSS HOLDINGS, LLC
		
	By:	 	 /s/ James Lauter

	Name:	 	James Lauter
	Title:	 	Senior Vice President and CFO
	
	HOME LOAN SERVICING SOLUTIONS, LTD.
		
	By:	 	 /s/ James Lauter

	Name:	 	James Lauter
	Title:	 	Senior Vice President and CFO

 Exhibit A 

Sale Supplements 
  

	1.	Sale Supplement, dated as of October 25, 2013, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser 

 

	2.	Sale Supplement, dated as of July 1, 2013, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser 

 

	3.	Sale Supplement, dated as of May 21, 2013, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser 

 

	4.	Sale Supplement, dated as of March 13, 2013, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser 

 

	5.	Sale Supplement, dated as of December 26, 2012, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser 

 

	6.	Sale Supplement, dated as of September 28, 2012, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser 

 

	7.	Sale Supplement, dated as of September 13, 2012, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser 

 

	8.	Sale Supplement, dated as of August 1, 2012, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser 

 

	9.	Sale Supplement, dated as of May 1, 2012, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser 

 

	10.	Sale Supplement, dated as of February 10, 2012, between Ocwen Loan Servicing, LLC, as Seller, HLSS Holdings, LLC, as Purchaser, and Home Loan Servicing Solutions, Ltd., as Purchaser

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]